Professor Jolanta Siller-Matula is an interventional cardiologist at the Department of Cardiology, Medical University of Vienna. She is a leader of a clinical research group and an expert in thrombosis research with 15 years of experience. She has carried out over 30 clinical studies with a focus on personalized antithrombotic therapy in patients undergoing percutaneous coronary and structural cardiac interventions or presenting with atrial fibrillation. More recently, she has expanded her research interests to include the investigation of SGLT2 inhibition in acute myocardial infarction and acute heart failure.
Her publications (>125; IF>600; >5000 citations; h-index: 38; i10-index=84) have added to a debate in the cardiology community surrounding pheno- and genotyping for prediction of the efficacy and safety of conventional antithrombotic treatment and use of biomarkers in patients presenting with acute coronary syndrome.
Her competencies include planning and performing clinical trials, platelet function testing, biostatistics, path analyses, meta-analyses, modeling of scores and algorithms. She has a great experience in teaching and has been invited over 100 times to give lectures at medical conferences and for general public.